Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Brief Genetics Reports

Assessment of the Role of Common Genetic Variation in the Transient Neonatal Diabetes Mellitus (TNDM) Region in Type 2 Diabetes

A Comparative Genomic and Tagging Single Nucleotide Polymorphism Approach

  1. Anna L. Gloyn12,
  2. Deborah J.G. Mackay3,
  3. Michael N. Weedon2,
  4. Mark I. McCarthy1,
  5. Mark Walker4,
  6. Graham Hitman5,
  7. Bridget A. Knight2,
  8. Katharine R. Owen12,
  9. Andrew T. Hattersley2 and
  10. Timothy M. Frayling2
  1. 1Diabetes Research Laboratories, Oxford Centre for Diabetes, Endocrinology & Metabolism, Oxford, U.K
  2. 2Institute of Biomedical and Clinical Science, Peninsula Medical School, Exeter, U.K
  3. 3Wessex Regional Genetics Laboratories, Salisbury District Hospital, Salisbury, U.K
  4. 4Department of Medicine, School of Medicine, University of Newcastle, Newcastle, U.K
  5. 5Centre of Diabetes & Metabolic Medicine, Barts and the London, Queen Mary School of Medicine and Dentistry, University of London, London, U.K
  1. Address correspondence and reprint requests to Dr. Timothy M. Frayling St. Lukes Laboratories, Peninsula Medical School, Magdalen Road, Exeter, EX1 2LU, U.K. E-mail: tim.frayling{at}pms.ac.uk
Diabetes 2006 Aug; 55(8): 2272-2276. https://doi.org/10.2337/db06-0216
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • FIG. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Schematic representation of the ZAC/PLAGL1 gene. Schematic representation of the ZAC/PLAGL1 gene region illustrating the nine exons of ZAC and the position of the 26 SNPs identified. tSNPs are indicated by arrows, and the 26 SNPs identified are shown as diamonds.

  • FIG. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Linkage disequilibrium (LD) pattern across the ZAC/PLAGL1 region. Schematic representation of the linkage disequilibrium across the ZAC gene region by measurements of D′ (A) and r2 (B) for 26 SNPs. SNPs with the highest level of linkage disequilibrium are shown in red, and those with the lowest level of linkage disequilibrium are shown in blue.

Tables

  • Figures
  • TABLE 1

    Clinical details of study subjects

    Case subjectsControl subjectsFamily study probandsUnaffected siblings
    n1,9881,606536208
    Male (%)59515844
    Age at diagnosis or testing (years)*51 (45–57)31 (28–35)41 (36–47)49 (43–55)
    BMI (kg/m2)30.1 (26.7–34.2)24.8 (22.2–27.8)33.0 (28.9–37.4)28.1 (25.4–31.2)
    Treatment D/O/I (%)11/63/26†20/59/21†
    • Data are median (interquartile range) unless otherwise indicated. Only successfully genotyped subjects were included. No clinical details were available for the European Cell Culture Collection population control samples, so control characteristics are for the Exeter Family Study samples only.

    • *

      * Age at diagnosis for case subjects; age at study for control subjects.

    • †

      † Control subjects and unaffected siblings were not on treatment. D/O/I, diet/oral hypoglycemic agent/insulin.

  • TABLE 2

    Case and control subjects’ tSNP analysis

    SNP nameAlleles (1/2)Allele 1 frequency in control subjectsOR (95% CI) for allele 1P
    rs7761382C/T0.570.98 (0.89–1.08)0.71
    rs6570592C/T0.461.01 (0.92–1.11)0.89
    rs3818092G/C0.230.94 (0.84–1.05)0.25
    rs2076683T/G0.441.04 (0.95–1.15)0.42
    rs2257104C/A0.571.01 (0.92–1.11)0.86
    rs2076684C/G0.090.95 (0.80–1.14)0.58
    rs2064495T/C0.791.08 (0.96–1.21)0.20
    Exon8-8498C>TT/C0.151.06 (0.93–1.21)0.36
    rs2268447T/C0.310.98 (0.89–1.08)0.68
    rs2247408T/C0.310.98 (0.89–1.09)0.73
    rs2328536T/C0.691.02 (0.92–1.13)0.68
    rs2273323T/C0.061.02 (0.84–1.25)0.84
    rs2092894G/A0.551.02 (0.93–1.12)0.71
    rs6937128G/A0.250.98 (0.88–1.10)0.77
    rs2064661C/T0.821.00 (0.88–1.13)0.99
    • The case-control study had 80% power to detect an OR >1.2–1.4. The simple allelic OR model is presented. Multiplicative, recessive, and dominant models were all tested and were also negative.

  • TABLE 3

    Family-based tSNP analysis

    SNP nameAlleles (1/2)Overall observed allele 1 transmissionOverall expected allele 1 transmissionOverall P
    rs7761382C/T2692670.87
    rs6570592C/T2702540.14
    rs3818092G/C1411480.47
    rs2076683T/G2482530.70
    rs2257104C/A2632580.66
    rs2076684C/G40500.05
    rs2064495T/C1961890.46
    Exon8-8498C>TT/C1141110.70
    rs2268447T/C1851950.32
    rs2247408T/C1761880.20
    rs2328536T/C2262170.34
    rs2273323T/C41490.12
    rs2092894G/A2422390.81
    rs6937128G/A1721650.47
    rs2064661C/T1391540.07
    • Results were analysed using the transmission-disequilibrium test/sib transmission-disequilibrium test methods. The family study had 80% power to detect ORs of 1.4 and 1.68 for MAFs of 50% and 10%, respectively.

PreviousNext
Back to top

In this Issue

August 2006, 55(8)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Assessment of the Role of Common Genetic Variation in the Transient Neonatal Diabetes Mellitus (TNDM) Region in Type 2 Diabetes
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Assessment of the Role of Common Genetic Variation in the Transient Neonatal Diabetes Mellitus (TNDM) Region in Type 2 Diabetes
Anna L. Gloyn, Deborah J.G. Mackay, Michael N. Weedon, Mark I. McCarthy, Mark Walker, Graham Hitman, Bridget A. Knight, Katharine R. Owen, Andrew T. Hattersley, Timothy M. Frayling
Diabetes Aug 2006, 55 (8) 2272-2276; DOI: 10.2337/db06-0216

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Assessment of the Role of Common Genetic Variation in the Transient Neonatal Diabetes Mellitus (TNDM) Region in Type 2 Diabetes
Anna L. Gloyn, Deborah J.G. Mackay, Michael N. Weedon, Mark I. McCarthy, Mark Walker, Graham Hitman, Bridget A. Knight, Katharine R. Owen, Andrew T. Hattersley, Timothy M. Frayling
Diabetes Aug 2006, 55 (8) 2272-2276; DOI: 10.2337/db06-0216
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The Krüppel-Like Factor 11 (KLF11) Q62R Polymorphism Is Not Associated With Type 2 Diabetes in 8,676 People
  • CHRM3 Gene Variation Is Associated With Decreased Acute Insulin Secretion and Increased Risk for Early-Onset Type 2 Diabetes in Pima Indians
  • Polymorphism in the Transcription Factor 7-Like 2 (TCF7L2) Gene Is Associated With Reduced Insulin Secretion in Nondiabetic Women
Show more Brief Genetics Reports

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.